<DOC>
	<DOCNO>NCT01180569</DOCNO>
	<brief_summary>The purpose study see treatment Lenalidomide , pill give mouth 7.5 month ( 30 week total ) , delay growth lymphoma shrink lymphoma . Lenalidomide pill approve Food Drug Administration ( FDA ) . It use treat form cancer-like illness ( myelodysplastic syndrome ( MDS ) combination dexamethasone patient multiple myeloma ( MM ) receive least 1 prior therapy . MDS MM cancer blood ) . This drug work stimulate body 's immune system reduce blood supply cancer cell . Cancer cell need blood live grow . In study , drug consider new experimental drug learn work form lymphoma .</brief_summary>
	<brief_title>Lenalidomide Therapy In Previously Untreated , Advanced Stage Follicular Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Histologically confirm diagnosis follicular lymphoma : grade I , II , IIIA , ( define WHO classification3 ) review hematopathologist Memorial Hospital No prior treatment lymphoma permit . Measurable evaluable disease permit ; least one peripheral site amenable FNAs Laboratory test result within range Absolute neutrophil count ≥ 2000 Platelet count ≥ 150,000 Creatinine clearance ≥ 60 mL/min ( may actual calculate CockroftGault formula Total bilirubin 1.5 x ULN AST ( SGOT ) ALT ( SGPT ) ≤ 3 x ULN . Karnofsky performance status &gt; 70 % The patient may previous history radiation therapy . Patient guardian must able sign voluntary write consent . Male female patient 18 year age great . Females childbearing potential ( FCBP ) † must negative serum pregnancy test sensitivity least 50 mIU/mL within 10 14 day prior within 24 hour start lenalidomide must either commit continued abstinence heterosexual intercourse begin TWO acceptable method birth control , one highly effective method one additional effective method AT THE SAME TIME , least 28 day start take lenalidomide . FCBP must also agree ongoing pregnancy test . Men must agree use latex condom sexual contact FCBP even successful vasectomy . All patient must counsel minimum every 28 day Fetal Exposure , Pregnancy Testing Guidelines Acceptable Birth Control Methods ( Appendix B ) , also Appendix C : Education Counseling Guidance Document . Able take aspirin ( 81 mg , already aspirin ) daily prophylactic anticoagulation ( Patients intolerant ASA may use low molecular weight heparin ) . Although recommended prophylactic anticoagulation , warfin may use clode monitor INR . Histologic diagnosis follicular grade 3B aggressive nonHodgkin 's lymphoma . Histologic evidence transformation low grade/indolent NHL aggressive NHL . PET uptake involve site great 12 ( suggest histologic transformation ) . Regional lymphoma ( peripheral stage I II ) eligible involved field irradiation.Staging fulfills criteria initial treatment accord GELF criteria2 advance stage disease ( peripheral stage I II amenable involved field irradiation ) . None follow present : 1 . A nodal extranodal mass diameter &gt; 7 cm , 2 . Involvement least three nodal site [ diameter &gt; 3 cm ] , 3 . Systemic symptom , 4 . Symptomatic splenomegaly , 5 . Ureteral compression . Patients known history HIV , Hepatitis B C seropositivity . Patients stool positive H. Pylori ( patient eligible protocol 07038 ) . Evidence laboratory TLS CairoBishop Definition Tumor Lysis Syndrome ( see Appendix E ) . Subjects may enrol upon correction electrolyte abnormality . Patients require therapy systemic corticosteroid . Prior history malignancy within past five year concurrent malignancy , exception cutaneous basal cell carcinoma carcinoma situ uterine cervix . Pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Lenalidomide</keyword>
	<keyword>10-022</keyword>
</DOC>